By Raechel Thankam Job and Richa Naidu July 30 (Reuters) – Sluggish European demand and weak respiratory sales raised doubts on Thursday about whether Haleon can meet its sales targets, sending shares
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Chinese investors rush into US stocks as Beijing opens wider path overseas
SHANGHAI, Sept 16 (Reuters) - Chinese investors are piling into foreign assets, especially U.S. stock…
Sleep in total darkness to maintain heart health, researchers say
Washington (dpa) - Many a pop song has nudged us to turn the lights down…
Bejlek, Stearns make Guadalajara quarters
VIDEO SHOWS: HIGHLIGHTS FROM DAY THREE OF GUADALAJARA OPEN - A WTA 500 TOURNAMENT COMPLETE…
